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The effects of the exposure of mitogen-stimulated human lymphocytes from aged subjects to low-frequency pulsed elec- 
tromagnetic fields (PEMFs) were studied by measuring the production of interleukin-2 (IL-2) and the expression of IL-2 
receptor. PEMF-exposed cultures that presented increased PH]thymidine incorporation showed lower amounts of IL-2 
in their supernatants, but higher percentages of IL-2 receptor-positive cells and of T-activated lymphocytes. Taken to- 
gether, these data suggest that PEMFs were able to modulate mitogen-induced lymphocyte proliferation by provoking 
an increase in utilization of IL-2, most likely acting on the expression of its receptor on the plasma membrane. 
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1. INTRODUCTION 
Numerous sources of electrophoretic fields exist 
in nature and in occupational and residential en- 
vironments. In nearly all instances, these fields 
pose no obvious threat to human health or safety 
and are generally considered as an inevitable by- 
product of modern technology. However, public 
awareness of the ubiquitous nature of these fields 
and growing controversy over their potential ef- 
fects on living systems are currently stimulating the 
scientific community to investigate accurately their 
biological effects. In fact, there is evidence that 
such fields, which do not produce macroscopic 
thermal effects, affect the growth and DNA syn- 
thesis of many cell types, including lymphocytes 
[l-7]. 
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In previous studies, we showed that PEMFs, 
although devoid of any effect on DNA repair syn- 
thesis [8], were able to increase phytohaemag- 
glutinin (PHA)-induced lymphocyte proliferation, 
and that such an effect was particularly evident 
when cells from old donors were studied [9, lo]. 
Here, we report that PEMFs could favour lym- 
phocyte proliferation by increasing utilization of 
the growth factor interleukin-2 (IL-2) and expres- 
sion of the IL-2 receptor on the plasma membrane. 
2. MATERIALS AND METHODS 
2.1. Subjects 
Lymphocytes from aged subjects (86-90 years old, mean age 
88.2 f 0.8 years) were used to assess production and utilization 
of interleukin-2 (IL-2). Expression of the IL-2 receptor (IL-2R) 
on cell membranes was evaluated in 10 other aged subjects 
(84-96 years old, mean age 87.4 f 1.2 years); in six of them 
(85-96 years old, mean age 88.0 + 1.6 years) the percentage of 
activated T-lymphocytes was also determined. All aged subjects 
were in good condition, as assessed by accurate clinical evalua- 
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tion; in addition, more than 70 haematological nd biochemical 
parameters were evaluated for each subject in order to confirm 
the clinical status. 
2.2. Isolation of peripheral blood lymphocytes and 
mitogen-stimulated cultures 
Immediately before experiments, 30-40 ml heparinized 
venous blood was obtained and peripheral ymphocytes were 
separated by density gradient centrifugation, according to 
Boyum [ll]. PHA-stimulated cultures were performed as 
described [12]. Briefly, 0.1 ml cell suspension containing lo5 
viable lymphocytes in complete medium (RPM1 1640, contain- 
ing 2 mM glutamine, 100 U/ml penicillin, 100 rg/ml strepto- 
mycin and 10% inactivated human AB serum from a pool of IO 
donors) was distributed in microplate wells (Falcon Plastic, Los 
Angeles, CA) and stimulated by adding 0.1 ml complete 
medium containing different doses of mitogen (PHA-P, Difco, 
Detroit, Ml); final concentrations 1 and 10 ,ul/ml). Cultures 
were incubated in a humidified atmosphere of 5% CO;! and 95% 
air for different periods of time, i.e. 18, 24, 48 or 72 h. 
[‘H]Thymidine ([3H]TdR) was added for the final 6 h of culture, 
and microplates were treated as described in [12]. 
2.3. In vitro production and measurement of interleukin-2 
(Peripheral blood lymphocytes (PBLs) from aged subjects were 
cultured for 24 or 48 h at lo6 cells/ml under the conditions 
described above, either without or with PHA at 1 or lOpl/ml, in 
quadruplicate, and were exposed to PEMFs or left unexposed. 
At the end of the culture periods cell supernatants were collected 
after centrifugation, and stored at - 20°C until assay. Separate 
cultures under the same experimental conditions were kept for 
72 h and pulsed with [‘H]TdR to correlate the effect of PEMF 
exposure on IL-2 production to that on DNA synthesis. The 
quantitative microassay described by Gillis et al. [13] was used 
for measurement of in vitro produced IL-2 activity. Briefly, 
5000 CTLL-A cells (a cytolytic murine T cell line) were seeded in 
duplicates in each well of a 96-well culture microplate, with 
serial dilutions of supernatants to be assayed and known stan- 
dards of recombinant IL-2 (Biogen SA, Base], Switzerland), or 
immunochemically purified IL-2 (gift from Professor S. 
Venuta, Naples, Italy) or reference Jurkat IL-2 (BRMP, NIH, 
Bethesda, MD). After 24 h of culture, 0.5&i [‘H]TdR was add- 
ed to each well for 18 h. Results on [‘H]TdR incorporation were 
calculated by probit analysis for each supernatant vs standards, 
and are expressed as reference units/ml. 
2.4. IL-2 receptor expression and T-activated lymphocytes 
PBLs from aged subjectes were cultured and stimulated with 
the optimal dose of PHA (1 pi/ml) as described above. After ex- 
posure to PEMFs for 18 h cells were harvested for fluorescence- 
activated cell sorter (FACS) analysis (by a FACSTAR, Becton- 
Dickinson FACS Division, Mountain View, USA), washed 
twice in cold PBS with 5% fetal calf serum (FCS), resuspended 
at lo6 cells/ml in 100~1 PBS containing FCS and supplemented 
with 10 ~1 monoclonal antibody (MoAb). Double fluorescence 
labelling was performed by simultaneous incubation with 
phycoerythrin (PE)- and fluorescein (FlTC)-labelled MoAbs. 
The following MoAbs from Becton-Dickinson (Oxnard, USA) 
were used: (i) CD 25, i.e. anti-interleukin-2 Receptor MAb (anti- 
TAC); (ii) CD 3 viz. anti-T lymphocytes (Leu 4); (iii) anti-HLA 
Table 1 
IL-2 concentration and [‘H]TdR incorporation in PHA-stimulated PEMF-exposed lymphocytes 
from 4 aged subjects 
Subject PHA 
(&ml) 
[‘H]TdR 
incorporation IL-2 production 
24 h 48 h 
Control Exposed Control Exposed Control Exposed 
to PEMFs to PEMFs to PEMFs 
A 0 455 309 <0.5 <0.5 < 0.5 < 0.5 
1 14 191 37418 0.5 2 8 2 
10 2049 3 456 0.5 0.5 < 0.5 <0.5 
B 0 140 198 <0.5 <0.5 < 0.5 2 
1 43 233 73 120 8 5 15 0.5 
10 3 384 14 808 1 0.5 I5 0.5 
C 0 200 182 <0.5 <0.5 < 0.5 < 0.5 
1 121775 126918 6 2.5 12 9 
10 18094 30 027 0.7 0.5 20 1.5 
D 0 476 299 <0.5 <0.5 < 3 < 0.5 
1 46 375 49 155 2 4 7 10 
10 3 556 4 529 5 0.8 8 8 
Values of [3H]TdR incorporation are expressed in cpm; SE values are not reported since they never 
exceeded 5%. Data regarding the IL-2 concentrations are expressed in reference units/ml. See text 
for details 
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DR positive lymphocytes; this MAb recognizes B lymphocytes 
and T activated cells [14-171. After incubation for 30 min at 
4”C, cells were washed twice, resuspended in PBS without FCS 
and analyzed using a cytofluorimeter with a laser source which 
made it possible to excite FITC and PE simultaneously at a 
wavelength of 488 nm, and to separate the emitted light of FITC 
and of PE into two separate photomultipliers. A minimum of 
10000 cells from each sample was analyzed. 
2.5. Characteristics of PEMFs and exposure conditions 
Microtitre plates were placed between a pair of Helmoltz coils 
(maintained parallel to the plates) powered by a pulse generator 
(Igea, Carpi, Italy). The same signal as used in a previous study 
was employed [7]. Briefly, the pulse duration was about 2 ms 
and the repetition rate 50 Hz, yielding a duty cycle of l/10. The 
intensity of the magnetic field was 2.5 mT, the average time 
variation of the magnetic field being of the order of 1 T/s. The 
induced voltage, as detected with a coil probe comprising 50 
turns (diameter 0.5 cm), was about 2 mV. Taking into account 
the size of each well and its position with respect o the magnetic 
flw lines, the induced electric field inside each well was in the 
plane parallel to the microtitre plate surface, and the maximum 
field (maximum internal radius) was estimated as 0.02 mV/cm 
[18]. Control cultures were maintained in the same incubator at 
a distance where no electromagnetic field was detectable using 
the above coil. Cultures were exposed for different time periods, 
viz. 18 h for evaluation of IL-2 receptor-positive cells and 
percentage of T-activated lymphocytes, and 24 and 48 h for stu- 
dying the production of IL-2. No thermal effect was produced 
by the exposure system used, as measured either by a precision 
thermometer placed in a water bath close to the microplates or 
by direct assessment of the temperature within the microwells 
using a specially designed thermoresistor. 
3. RESULTS 
As one of the major effects of PEMFs was 
observed in lymphocytes from old people whose 
reduced proliferation is known to be caused, at 
least in part, by diminished production and utiliza- 
tion of IL-2, we measured this growth factor in 
unexposed and PEMF-exposed cultures of lym- 
phocytes from old donors, stimulated with optimal 
and supraoptimal doses of PHA. The results 
reported in table 1 suggest hat PEMFs did not in- 
crease IL-2 production. In fact, the IL-2 concentra- 
tion at 24 h was similar in PEMF-exposed and 
unexposed cultures. However, a marked decrease 
in IL-2 at the 48th hour was observed but only in 
those cultures which responded to PEMF exposure 
with increased [3H]TdR incorporation, i.e. sub- 
jects A (PHA l), B (PHA 1, 10) and C (PHA 10). 
As the data in table 1 suggest that PEMFs could in- 
crease lymphocyte proliferation by increasing 
utilization of IL-2, we considered it to be worth- 
while to determine the expression of IL-2 receptor 
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Fig.1. Exposure to PEMFs increase the percentage of IL-2 
receptor (IL-2R)-positive (A) and T-activated lymphocytes (B) 
in PHA-stimulated cultures from aged subjects. Open bars: 
unexposed cells; filled bars, PEMF-exposed cells; each bar 
refers to one subject. Statistical analysis was performed by 
paired Student’s t-test: percentage of IL-2R-positive cells (mean 
f SE): unexposed = 45.1 + 2.9; PEMF-exposed = 
55.2 k 3.l;pcO.OOl; percentage of T-activated (CD3 + HLA- 
DR+) lymphocytes (mean + SE): unexposed = 45.6 f 4.6; 
PEMF-exposed = 53.8 k 5.O;p<O.O1. 
on PEMF-exposed lymphocytes. Fig. 1A shows 
that expression of IL-2 receptor on lymphocyte cell 
membranes, as assessed by cytofluorimetric 
analysis with CD MAb, was markedly increased in 
PEMF-exposed lymphocytes, this effect being evi- 
dent in 10 out of 10 aged subjects. In 6 of these sub- 
jects the percentage of activated T lymphocytes 
was also assessed by counting the percentage of 
CD3 positive and anti-HLA DR positive cells. The 
data reported in fig. 1B show that in 5 out of 6 
cases a marked increase in percentage of activated 
T lymphocytes was observed after PEMF ex- 
posure. 
4. DISCUSSION 
Here, one of the possible mechanisms of action 
of PEMFs was investigated. Several studies on pro- 
liferation of human lymphocytes had suggested 
that one of the critical steps involved was expres- 
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sion of the receptor for a critical lymphocyte 
growth factor, such as IL-2 [19-231. The fact that 
PEMFs were particularly effective in lymphocytes 
from old people, whose impaired proliferation has 
been ascribed either to defective production of IL-2 
or to defective expression of high-affinity IL-2 
receptors [24,25], supports this hypothesis. Even if 
the MoAb used in the present study were unable to 
discriminate between low- and high-affinity IL-2 
receptors [26,27], these data, together with those 
reported in table 1, would suggest hat functional 
(high-affinity) receptors might be involved in the 
PEMF-induced augmentation of IL-2 utilization. 
The possibility of the involvement of other 
growth factors for T lymphocytes besides IL-2 can- 
not be excluded and deserves further attention. 
We are currently studying the effects of PEMFs 
at the molecular level to ascertain whether the ex- 
pression of mRNAs for IL-2 and IL-2 receptor is 
increased by PEMF exposure as would be predicted 
on the basis of the present data. 
The interest of this work for the assessment of 
risk factors associated with environmental ex- 
posure to PEMF fields similar to those used in the 
present study should also be considered. 
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